U.S. National Institutes of Health
U.S. National Institutes of Health


IDRankTitleRecruitmentStudy ResultsConditionsInterventionsURL
108811108811Effects of High-dose Intravenous Selenium (Selenase®) in Adult Patients Subjected to Elective All-cause Heart SurgeryCompletedNo Results AvailableHeart; Surgery, Heart, Functional Disturbance as Result|Self EfficacyDrug: Selenasehttps://ClinicalTrials.gov/show/NCT01141556
108812108812Feasibility and Efficiency Study of Leukemic Cell Mobilization With Plerixafor InjectionCompletedNo Results AvailableAcute Myeloid LeukemiaDrug: Plerixafor (mozobil)https://ClinicalTrials.gov/show/NCT01141543
108813108813Deep Sequencing of the Breast Cancer TranscriptomeWithdrawnNo Results AvailableBreast CancerOther: No interventionhttps://ClinicalTrials.gov/show/NCT01141530
108814108814Predictors of Teen Smoking-cessationRecruitingNo Results AvailableCigarette SmokingBehavioral: Not-On-Tobacco smoking cessation programhttps://ClinicalTrials.gov/show/NCT01141517
108815108815Effect of Oral Adenosine-triphosphate (ATP) on Human Muscle PerformanceCompletedNo Results AvailableHealthy SubjectsDietary Supplement: PeakATP 250|Dietary Supplement: Placebo|Dietary Supplement: PeakATP 400|Dietary Supplement: PeakATP 400 plus proprietary blendhttps://ClinicalTrials.gov/show/NCT01141504
108816108816Trivalent Ganglioside Vaccine With Immunological Adjuvant or Immunological Adjuvant Alone in Metastatic Sarcoma Patients Who Are Rendered Disease FreeActive, not recruitingNo Results AvailableSarcomaBiological: Trivalent ganglioside vaccine|Biological: OPT-821https://ClinicalTrials.gov/show/NCT01141491
108817108817Proton Beam Radiotherapy Plus Sorafenib Versus Sorafenib for Patients With Hepatocellular Carcinoma Exceeding San Francisco CriteriaRecruitingNo Results AvailableCarcinoma, HepatocellularRadiation: Proton Beam Radiotherapy|Drug: Sorafenibhttps://ClinicalTrials.gov/show/NCT01141478
108818108818Real-world Effectiveness of Combination Therapy in AsthmaCompletedNo Results AvailableAsthmaDrug: Fluticasone / formoterol metered dose inhaler|Drug: Fluticasone / salmeterol dry powder inhaler|Drug: Budesonide / formoterol dry powder inhaler|Drug: Fluticasone / salmeterol dry powder inhaler|Drug: Fluticasone / salmeterol metred dose inhaler|Drug: BUD/FOR dry powder inhalerhttps://ClinicalTrials.gov/show/NCT01141465
108819108819Real-life Effectiveness and Cost-effectiveness of Qvar Versus FP and BDP in the Management of COPDCompletedNo Results AvailableChronic Obstructive Pulmonary DiseaseDrug: Extra-fine hydrofluoroalkane beclomethasone MDI|Drug: Chlorofluorocarbon beclomethasone metered dose inhaler|Drug: Fluticasone propionate metred dose inhaler|Drug: Fluticasone propionate metred dose inhaler|Drug: Hydrofluoroalkane beclomethasone metred dose inhaler|Drug: Chlorofluorocarbon beclomethasone dipropionatehttps://ClinicalTrials.gov/show/NCT01141452
108820108820Real-world Effectiveness and Cost-effectiveness of Leading Inhaled Corticosteroids in Asthma ManagementCompletedNo Results AvailableAsthmaDrug: Extra-fine hydrofluoroalkane-beclomethasone dipropionate|Drug: Extra-fine hydrofluoroalkane-beclomethasone dipropionate|Drug: Fluticasone propionate|Drug: Beclomethasone dipropionate|Drug: fluticasone propionate|Drug: Chlorofluorocarbon beclomethasone dipropionatehttps://ClinicalTrials.gov/show/NCT01141439
108821108821Halifax Treatment Refractory Depression TrialRecruitingNo Results AvailableDepressionBehavioral: Intensive Short-term Dynamic Psychotherapy|Behavioral: Secondary Care Treatment as Usualhttps://ClinicalTrials.gov/show/NCT01141426
108822108822Dose Escalation With Remicade® and Orencia®CompletedNo Results AvailableRheumatoid Arthritishttps://ClinicalTrials.gov/show/NCT01141413
108823108823The Effect of Patient Cost-Sharing on Antidepressant and Adjunctive Therapy UseCompletedNo Results AvailableDepressive Disorder, Majorhttps://ClinicalTrials.gov/show/NCT01141400
108824108824Outcomes in MEasurement-Based TreatmentCompletedNo Results AvailableDepressive Disorder, Majorhttps://ClinicalTrials.gov/show/NCT01141387
108825108825Application of Auriculotherapy on Nursing Professional Stress LevelsCompletedHas ResultsStressOther: auriculotherapy by needles|Other: auriculotherapy by seedshttps://ClinicalTrials.gov/show/NCT01141374
108826108826Feasibility of Home-based Measurement of Walking Capacity Using Global Positioning System in Peripheral Artery DiseaseCompletedNo Results AvailablePeripheral Artery DiseaseProcedure: GPS recording(s) of walking capacity in PAD patientshttps://ClinicalTrials.gov/show/NCT01141361
108827108827The Weight-Wise Weight Loss Translation StudyCompletedNo Results AvailableOverweight|Obesity|Cardiovascular DiseaseBehavioral: Special Intervention|Behavioral: Delayed Interventionhttps://ClinicalTrials.gov/show/NCT01141348
108828108828Polypropylene Mesh Versus Polytetrafluoroethylene (PTFE) Mesh in Inguinal Hernia RepairActive, not recruitingNo Results AvailablePhysical Function|Pain|Hernia|Wound Infection|Postoperative Complication|RecurrenceDevice: polypropylene mesh|Device: Infinit® PTFE mesh (WL Gore)https://ClinicalTrials.gov/show/NCT01141335
108829108829Cholestatic Drug-induced Liver InjuryRecruitingNo Results AvailableHepatitis, ToxicDrug: Ursodeoxycholic Acid|Drug: Placebohttps://ClinicalTrials.gov/show/NCT01141322
108830108830Evaluating the Combination of Everolimus and Sorafenib in the Treatment of Thyroid CancerActive, not recruitingNo Results AvailableThyroid CancerDrug: sorafenib with everolimushttps://ClinicalTrials.gov/show/NCT01141309
108831108831Fenofibrate in Combination With Ursodeoxycholic Acid (UDCA) in Primary Biliary CirrhosisWithdrawnNo Results AvailablePrimary Biliary CirrhosisDrug: fenofibrate|Drug: placebohttps://ClinicalTrials.gov/show/NCT01141296
108832108832Safety of BTDS in Subjects With Osteoarthritic (OA) Pain of Hip or Knee: A 6-Month Open-label Extension PhaseCompletedHas ResultsOsteoarthritisDrug: Buprenorphine transdermal patch|Drug: Buprenorphine transdermal patch|Drug: Buprenorphine transdermal patchhttps://ClinicalTrials.gov/show/NCT01141283
108833108833Comparative Pharmacokinetics of AFOLIA and Gonal-f® After Single Subcutaneous ApplicationCompletedNo Results AvailableHealthyDrug: AFOLIA|Drug: Gonal-fhttps://ClinicalTrials.gov/show/NCT01141270
108834108834Study of Angiocal® in Patients With Solid Tumors, Investigating Safety, Tolerability, Blood Concentration of Study DrugCompletedNo Results AvailableSolid TumorDrug: Angiocal® (PRS-050-PEG40)https://ClinicalTrials.gov/show/NCT01141257
108835108835Temsirolimus, Irinotecan Hydrochloride, and Temozolomide in Treating Younger Patients With Relapsed or Refractory Solid TumorsCompletedNo Results AvailableUnspecified Childhood Solid Tumor, Protocol SpecificDrug: temsirolimus|Drug: temozolomide|Drug: irinotecan hydrochloride|Other: laboratory biomarker analysishttps://ClinicalTrials.gov/show/NCT01141244
108836108836Acupuncture in Treating Dry Mouth Caused By Radiation Therapy in Patients With Head and Neck CancerRecruitingNo Results AvailableHead and Neck Cancer|Long-term Effects Secondary to Cancer Therapy in Adults|Oral Complications of Chemotherapy and Head/Neck Radiation|Radiation Toxicity|XerostomiaProcedure: Acupuncturehttps://ClinicalTrials.gov/show/NCT01141231
108837108837Internet-Based Clinical Information and Blood Sample Collection From Patients With Non-Small Cell Lung Cancer Who Never Smoked CigarettesTerminatedNo Results AvailableLung CancerOther: internet-based protocol and physician referralhttps://ClinicalTrials.gov/show/NCT01141218
108838108838HIV-1 Peptide Immunisation of Individuals in West Africa to Prevent DiseaseCompletedHas ResultsAids, Cdc Group IBiological: AFO-18|Drug: Salinehttps://ClinicalTrials.gov/show/NCT01141205
108839108839The Effect of Vitamin D Supplementation on Glucose Metabolism in Non-Diabetic African American AdultsCompletedNo Results AvailableType 2 DiabetesDietary Supplement: vitamin D3, cholecalciferol|Dietary Supplement: Inactive comparatorhttps://ClinicalTrials.gov/show/NCT01141192
108840108840The Impact of Renal Impairment on the Pharmacokinetic and Pharmacodynamic of LEO 27847CompletedNo Results AvailableRenal ImpairmentDrug: LEO 27847https://ClinicalTrials.gov/show/NCT01141179

* Görseller ve İçerik tekif hakkına sahip olabilir